SEC Filing Analysis: Castellum, Inc. (CTM)

Executive Summary

• Trading Significance: High
• Key Takeaway: The President & CEO, Glen R. Ives, was granted stock options to purchase 500,000 shares, representing a potential dilution of over 0.5% to existing shareholders, which is a material event for a company of this size.
• Market Impact: Neutral in the short-term as it's a non-cash grant, but it signals long-term incentive alignment and highlights potential future dilution upon exercise.

Company Information

Field	Value
Company	Castellum, Inc.
Ticker Symbol	CTM
CIK	0001877939
Industry	SERVICES-MANAGEMENT CONSULTING SERVICES

Insider Information

Field	Value
Name	Ives Glen R
CIK	0001947023
Title/Position	President, Chief Executive Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-11
Transaction Code	A (Award)
Security Type	Stock Options
Shares Involved	500,000
Price Per Share	$0.00
Total Value	$0
Shares Owned After	500,000 (options)
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.0%
Shares Transacted	500,000
% of Shares Outstanding	0.54%
Post-Transaction Ownership	500,000 options (potential 0.54% of outstanding)
Materiality Assessment	Highly Significant

Impact Evaluation

• Market Cap Context: For Castellum, a nano-cap company with a market capitalization of approximately $110 million, an equity grant of this size is a notable event. While the immediate transaction value is $0, the potential value upon exercise is substantial.
• Ownership Concentration: This grant establishes the CEO's derivative position in the company. His ownership of 500,000 options represents a potential 0.54% stake, aligning his financial interests with those of shareholders.
• Dilution Impact: The 500,000 shares underlying the options represent 0.54% of the 93,000,584 shares outstanding. This level of potential dilution crosses the 0.5% threshold for high significance, meaning it could materially impact earnings per share and ownership percentages for existing shareholders if and when the options are exercised.
• Transaction Significance: The significance is high not because of the dollar value of the grant, but because of the size of the potential stake relative to the company's total shares outstanding. It's a material grant of equity-based compensation.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Stock option grants are a common form of executive compensation and do not represent an open market transaction. While it aligns executive and shareholder interests, the primary impact is the potential for future dilution, which is not an immediate price catalyst.

Volume & Sentiment

• Expected Volume Impact: Low. As this is not an open-market trade, it is unlikely to directly influence trading volume.
• Sentiment Indicator: Neutral. The grant can be viewed as a standard part of executive compensation designed to incentivize performance. It is neither explicitly bullish nor bearish.

Investment Insights

Positive Market Indicators

• Incentive Alignment: The grant aligns the CEO's long-term interests with share price appreciation, as the options are only valuable if the stock price exceeds the $1.19 exercise price.

Risk Factors

• Potential Dilution: The primary risk for existing investors is the 0.54% dilution that will occur if these options are exercised. For a small company, every percentage point of dilution is meaningful.
• Executive Compensation: Large equity grants can sometimes be a point of concern for shareholders regarding the overall cost of executive compensation.

Key Takeaways

1. High Significance due to Dilution: The grant of 500,000 options is highly significant because it represents 0.54% of total shares outstanding, a material level of potential dilution.
2. CEO Incentive: This is a non-cash compensation event designed to retain and motivate the CEO, tying his future earnings to the company's stock performance.
3. Future Event to Watch: The key event for investors will be the future exercise of these options, which would involve the issuance of new shares and a cash inflow to the company (500,000 shares * $1.19/share).

Additional Context

Transaction Notes

• Vesting Schedule: The options were issued pursuant to the company's stock incentive plan and vest ratably over twenty months, starting December 1, 2025. This ensures the executive's continued service to unlock the full value.
• Exercise & Expiration: The options have an exercise price of $1.19 and expire on November 10, 2032.